Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03462394 · ClinicalTrials.gov registry record
Increasing Patient Engagement in the Annual Well Visits Program
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 5,475
- Enrollment target
NCT03462394: Completed study, sponsored by NYU Langone Health.
NCT03462394 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 5,475 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03462394 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 5,475 participants
- Enrollment target
Study Summary
NYU Langone Health calls patients to remind them to schedule their annual well-health appointments (including annual well visit, mammograms, etc.). The proposed study will test different iterations of the call script with the goal of increasing call completion rate and the number of scheduled appointments within an appropriate timeframe.
Interventions
- OTHER Current Script
- OTHER Alternate Script Iterations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,475 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2019-07-24 |
What the finished NCT03462394 record still lists
NCT03462394 is an observational study that tracks outcomes without assigning an intervention. Its 5,475 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Current Script is the first listed.
NCT03462394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03462394 about?
NCT03462394 is a clinical study titled "Increasing Patient Engagement in the Annual Well Visits Program". NYU Langone Health calls patients to remind them to schedule their annual well-health appointments (including annual well visit, mammograms, etc.). The proposed study will test different iterations of the call script with the goal of increasing call completion rate and the number of scheduled appoin...
What is the current status of trial NCT03462394?
This trial is currently completed. The enrollment target is 5,475 participants. The study started on 2018-02-19. Estimated completion is 2019-07-24.
What interventions are being tested in trial NCT03462394?
The interventions under investigation include: Current Script (OTHER), Alternate Script Iterations (OTHER).
Who is sponsoring clinical trial NCT03462394?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI